Pharmacological treatment of combat-induced PTSD: A literature review

British Journal of Nursing

Volumn 19, Issue 5, 2010, Pages 318-321

  Bastien, Debra Lynn ^a  

^a UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

Benzodiazepines; Beta blockers; Pharmacology; Post traumatic stress disorder; PTSD; Selective serotonin reuptake inhibitors; Veterans

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SEROTONIN UPTAKE INHIBITOR;

HUMAN; PATIENT COMPLIANCE; PATIENT RIGHT; PATIENT SELECTION; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT; REVIEW; SOLDIER; STATISTICS; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; COMBAT DISORDERS; HUMANS; MILITARY PERSONNEL; PATIENT COMPLIANCE; PATIENT RIGHTS; PATIENT SELECTION; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 77952514351     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.5.47074     Document Type: Article

References (18)

1. Asnis GM, Kohn SR, Henderson M, Brown NL (2004) SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs 64(4): 383-404
2. Brady KT, Killeen TK, Brewerton TD, Lucerini S (2000) Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry 61(Suppl 7): 22-32. Retrieved from PILOTS Database
3. Bremner JD (2006) The relationship between cognitive and brain changes in posttraumatic stress disorder. Ann NY Acad Sci 1071: 80-6. Retrieved from PILOTS Database
4. David D, De Faria L, Mellman TA (2006) Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. Depress Anxiety 23(8): 489-91
5. Davidson J, Pearlstein T, Londborg P et al (2001) Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo controlled study. Am J Psychiatry 158(12): 1974-81
6. Doskoch P (2002) Can beta-blockers prevent PTSD? A first look. NeuroPsychiatry Reviews 3(2). Available at: www.neuropsychiatryreviews.com/ march02/ptsd.html (Accessed 1 March 2010)
7. Ellen S, Olver J, Norman T, Burrows GD (2008) The neurobiology of benzodiazepine receptors in panic disorder and post-traumatic stress disorder. Stress and Health 24(1): 13-21
8. Henry M, Fishman JR, Youngner SJ (2007) Propranolol and the prevention of post-traumatic stress disorder: Is it wrong to erase the 'sting' of bad memories? Am J Bioeth 7(9): 12-20
9. Hoffman EJ, Mathew SJ (2008) Anxiety disorders: a comprehensive review of pharmacotherapies. Mt Sinai J Med 75(3): 248-62
10. Kolber A (2006) Therapeutic forgetting: the legal and ethical implications of memory dampening. Vanderbilt Law Review 59(5): 1561-626
11. Londborg PD, Hegel MT, Goldstein SJ et al (2001) Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. Clin Psychiatry 62(5): 325-31
12. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001) Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 158(12): 1982-8
13. Pary R, Lewis S (2008) Prescribing benzodiazepines in clinical practice. Resident & Staff Physician 54(1). Available at: http://www.hcplive.com/ general/publications/Resident-and-Staff/2008/2008-01/2008-01-04 (Accessed: 1 March 2010)
14. Pitman RK, Saunders KM, Zusman RM et al (2002) Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51(2): 189-92
15. Reist C, Duffy JG, Cahill L, Fujimoto K (2001) Adrenergic blockade and emotional memory in PTSD. Int J Neuropsychopharmacol 4(4): 377-83
16. Baldwin D (2006) Serotonin noradrenaline reuptake inhibitors: a new generation of treatment for anxiety disorders. Int J Psychiatry Clin Pract 10(S2): 12-15
17. Barnett SD, Tharwani HM, Hertzberg MA, Sutherland SM, Connor KM, Davidson JRT (2002) Tolerability of fluoxetine in posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 26(2): 363-7
18. Davis LL, Frazier EC, Williford RB, Newell JM (2006) Long-term pharmacotherapy for post-traumatic stress disorder. CNS Drugs 20(6): 465-76